View Cart  

March 10, 2005

Vol. 2 No. 49

View Archived Issues

Sign Up Now

Conor Presents Positive PISCES Trial Results

Conor Medsystems presented 12-month follow-up data from its PISCES (Paclitaxel In-Stent Controlled Elution Study) clinical trial at the American College of Cardiology scientific session in Orlando, Fla., that supported the long-term safety and efficacy of Conor's novel cardiovascular stent technology.

Read More

FDA Clears Siemens' Smaller Ultrasound Catheter

Siemens has received 510(k) clearance from the FDA to market the new ACUSON AcuNav 8F ultrasound catheter.

Read More

Sutura Receives ISO 13485:2003 Certification for SuperStitch

Sutura has announced the completion of a successful audit leading to a number of certifications for the manufacture of the company's SuperStitch closure product line.

Read More

Sontra Completes SonoPrep Clinical Study

Rapid dermal anesthesia was achieved in a study using Sontra Medical's SonoPrep ultrasonic skin permeation followed by two minutes of active drug transport with iontophoresis, a needle-free method of delivering drugs through the skin using low-level electrical current, the company said.

Read More

Novadaq Reports Positive Results in CABG Study

Novadaq Technologies announced that Nimesh Desai and Stephen Fremes reported data on a 120-patient prospective study conducted at Sunnybrook and Women's College Health Sciences Centre in Toronto, Canada, using Novadaq's proprietary Spy Intra-operative Imaging System for the assessment of graft quality during Coronary Artery Bypass Surgery (CABG).

Read More

Syneron Secondary Offering Priced at $28 Per Share

Syneron Medical has priced the offering of 7 million of its ordinary shares being sold by selling shareholders at $28 per share.

Read More

Ambion Announces Continued Alliance With Wyeth

Ambion Diagnostics, a division of Ambion, has entered into a new agreement with Wyeth Pharmaceuticals to continue its alliance in the development and supply of cGMP-grade RNA that will be incorporated as a component in Wyeth's innovative vaccine program.

Read More

Biomet Receives FDA Approval for New Product

Biomet announced that the FDA has granted marketing clearance for its patented ArComXL Highly Crosslinked Polyethylene, an engineered polymer that has demonstrated a 47 percent to 64 percent volumetric wear rate reduction over Biomet's own ArCom Polyethylene.

Read More

Innocoll Granted Two Patents for Wound-Healing Products

Innocoll announced that its wholly owned subsidiary, Syntacoll AG, has been granted two important patents.

Read More

IVMD Announces Positive Results in Fetal Monitoring Trials

IVMD announced the results of recent clinical trials conducted in connection with its labor prediction device.

Read More

EP MedSystems Announces Sales of Product From Offshore Facility

EP MedSystems, a maker of electrophysiology products used in cardiac rhythm management, began shipping certain EP catheters to its customers from its offshore manufacturing efforts in Mexico.

Read More

ZymeQuest Exercises Option for Rights to Blood Platelet Technology

ZymeQuest, a company that discovers, develops and commercializes carbohydrate-modified blood products for use in transfusion medicine, has exercised its option to license worldwide rights to a new method of treating platelets developed by Brigham and Women's Hospital.

Read More

ThermoGenesis Seeks New Patent Review

Fresh off a U.S. Patent and Trademark Office ruling that overturned a patent related to the collection and preservation of stem cells, ThermoGenesis - which makes equipment used to store such cells -- has asked the government to consider rejecting the claims made in two more.

Read More

Cholestech Introduces C-Reactive Protein Test

Cholestech announced the introduction of the Cholestech LDX high sensitivity C-Reactive Protein (hs-CRP) test at the 54th Annual Scientific Session of the American College of Cardiology.

Read More